Citation: | ANQing, HELi-wei, WUHong-yan, HOUXian-bang, ZHANGHong-jiang, ZHUAn-hong, ZHANGXiao-ping, FANFang-tian. Mechanismof Cordycepin Promotes Tumor Immunity by Regulating PD-1 Receptor of CD4+T Lymphocytes[J]. Journal of Nanjing University of traditional Chinese Medicine, 2018, 34(5): 495-498. |
[1] |
BELLI C,TRAPANI D,VIALE G,et al. Targeting the microenvironment in solid tumors[J]. Cancer Treat Rev,2018,65:22-32.
|
[2] |
CHEN F, ZHUANG X, LIN L,et al. New horizons in tumor microenvironment biology: challenges and opportunities[J]. BMC Med,2015,13:45.
|
[3] |
MO Z,DU P,WANG G,et al. The multi-purpose tool of tumor immunotherapy: gene-engineered T cells[J]. J Cancer,2017,8(9):1690-1703.
|
[4] |
江汇源,姜斌,刘峰. 肿瘤免疫检查点疗法的研究进展[J]. 现代肿瘤医学,2017,25(6):990-993.
|
[5] |
田坤,何雯婷,李玉民,等. PD-1/PD-L1通路在肿瘤免疫逃逸中的研究进展[J]. 现代肿瘤医学,2016,24(21):3513-3516.
|
[6] |
程远,黎军和.PD-1/PD-L1抑制剂在肿瘤免疫治疗中的研究进展[J].广东医学,2016,37(21):1178-1182.
|
[7] |
余伯成,唐永范,唐亮,等.虫草素的药理作用研究进展[J].现代药物与临床,2011,26(5):349-352.
|
[8] |
严国俊,潘苏华,严辉,等.复方蛹虫草颗粒的制备工艺研究[J].南京中医药大学学报,2010,26(6):453-455.
|
[9] |
WAGNER M, POECK H, JAHRSDOERFER B, et al. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA[J]. J Immunol,2004,172(2):954-963.
|
[10] |
AU-YEUNG BB, SMITH GA, MUELLER JL,et al. IL-2 modulates the TCR signaling threshold for CD8 but not CD4 T cell proliferation on a single-cell level[J]. J Immunol,2017,198(6):2445-2456.
|